Vertaling van "ou coronary " (Frans → Nederlands) :

ACV Accident Cérébro-Vasculaire BIS Bispectral index BMS Bare Metal Stent CABG Coronary Artery Bypass Graft DES Drug Eluting Stent ECG Electrocardiogramme ESC European Society for Cardiology FA Fibrillation Auriculaire GP General Practitioner IABP Intra-Aortic Balloon Pump IAM Infarctus Aigue du Myocarde ICP Intervention Coronarienne Percutanée ICU Intensive Care Unit I-ECA Inhibiteur de l’Enzyme de Conversion de l’Angiotensine INVOS In Vivo Optical Spectroscopy IQ Indicateur de qualité NSTE-ACS Non-ST-Segment Elevation Acute Coronary Syndrome OPCAB Off-pump Coronary Artery Bypass POS Procédures Opérationnelles Standard (SOP) QERMID Quality Electronic Registration of Medical Implant Devices (RIZIV – INAMI) SCA Syndrome Coronarien Aigu SLA Service Level Agreement / Accords sur les niveaux de service STEMI ST-Elevation Myocardial Infarction TEE Trans Esophageal Echocardiography URL Uniform Resource Locator
ACE Angiotensin Converting Enzyme ACS Acuut Coronair Syndroom AMI Acuut Myocard Infarct BIS Bispectral index BMS Bare Metal Stent CABG Coronary Artery Bypass Graft CVA Cerebrovasculair Accident DES Drug Eluting Stent EKG Electrocardiogram ESC European Society for Cardiology GP General Practitioner IABP Intra-Aortic Balloon Pump INVOS In Vivo Optical Spectroscopy KI Kwaliteitsindicatoren NSTE-ACS Geen ST-segment verhoging, Acuut Coronair Syndroom OPCAB Off-pump coronary artery bypass PCI Percutane Coronaire Interventie QERMID Quality Electronic Registration of Medical Implant Devices (RIZIV – INAMI) SLA Service Level Agreement SOP Standard Operating Procedure STEMI ST-Elevatie Myocard Infarct TEE Trans Esophageal Echocardiography URL Uniform Resource Locator VKF Voorkamerfibrillatie

46. Kim C, Kwok YS, Heagerty P, Redberg R. Pharmacologic stress testing for coronary disease diagnosis: A meta-analysis.
44. Kim C, Kwok YS, Heagerty P, Redberg R. Pharmacologic stress testing for coronary disease diagnosis: A meta-analysis.

Kim C et al - Am.Heart J. 46 2001 meta analysis yes 82 studies Coronary disease diagnostic : maximum sensitivity with vasodilatator combined with SPECT, maximum specificity with vasodilatator combined with DSE.
Kim C et al - Am.Heart J. 44 2001 meta analysis yes 82 studies Coronary disease diagnostic : maximum sensitivity with vasodilatator combined with SPECT, maximum specificity with vasodilatator combined with DSE.

Indication pontage aorto-coronarien (CABG ou Coronary Artery Bypass Graft) vs. ICP
Indicatie CABG (Coronary Artery Bypass Graft) versus PCI

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-bl Lancet 362 : 782-788(2003)
Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-bli Lancet 362 : 782-788(2003)

J. Hypertension 21, 1771- 1773 (2003) The EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators.
J. Hypertension 21, 1771-1773 (2003) The EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators.

Dietary fat and risk of coronary heart disease: possible effect modification by gender and age.
Dietary fat and risk of coronary heart disease: possible effect modification by gender and VZe.

− Karpe F. Postprandial lipid metabolism in relation to coronary heart disease.
Karpe F. Postprandial lipid metabolism in relation to coronary heart disease.

Au moins 20 dossiers médicaux pour au moins 2 des interventions chirurgicales suivantes doivent être évaluées en ce qui concerne l'antibioprophylaxie: prothèse de hanche, pontage coronarien (coronary artery bypass graft, CABG), interventions colorectales (cancer).
Minimum 20 medische dossiers voor minstens 2 van volgende ingrepen dienen geëvalueerd te worden voor wat betreft de chirurgische antibioticaprofylaxe: plaatsing heupprothese, coronaire bypassoperatie (CABG), electieve colorectale ingreep.

Lancet 362, 782-788 (2003) H.D. White: Should all patients with coronary disease receive angiotensin-convertingenzyme inhibitors?
Lancet 362, 782-788 (2003) H.D. White: Should all patients with coronary disease receive angiotensin-converting-enzyme inhibitors?